Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The FDA approved oral semaglutide (Rybelsus) in 2019, and other oral GLP-1 medications like orforglipron are in development
Who Temi is for in California Temi is for adults in California who want medical weight loss with a GLP-1 compounded semaglutide or tirzepatide prescribed and monitored by a licensed physician
Related Stories Small changes in one heart protein cause distinct cardiomyopathies Planetary Health Diet lowers cardiovascular risk in older women Two heart nerve cell types sustain cardiac stability in mice Time to an outcome was assessed using a Cox proportional hazards model
Timing your largest meal to coincide with your lowest nausea windowtypically the 57 days after injectionallows you to eat adequate nutrition when tolerance is highest
Many patients report improvements in cardiovascular health, better blood sugar control, reduced joint pain, enhanced mobility, and a general increase in energy and self-confidence
